Is Atrial Fibrillation Part of Sick Sinus Syndrome?
Yes, atrial fibrillation is definitively a component of sick sinus syndrome, specifically manifesting as the "bradycardia-tachycardia syndrome" variant. 1
Understanding the Relationship
Sick sinus syndrome (SSS) encompasses a spectrum of sinoatrial dysfunction that includes not just bradycardia, but also paroxysmal atrial tachyarrhythmias. The bradycardia-tachycardia syndrome is characterized by the development of paroxysmal atrial tachyarrhythmias—including atrial fibrillation—in patients with sinus bradycardia or sinoatrial block 1. This is not a coincidental association but rather reflects the underlying pathophysiology of SSS.
The 2007 ESC Guidelines explicitly state that sinus node disease "encompasses not only disorders of the sinus node impulse formation or its conduction to the right atrium, but also a more widespread atrial abnormality that is the substrate for the development of atrial tachyarrhythmias" 1. This means AF is an integral manifestation of the disease process, not a separate condition.
The Bidirectional Relationship
The relationship between SSS and AF is bidirectional and mutually reinforcing:
- SSS predisposes to AF: The atrial remodeling and widespread atrial abnormality inherent to SSS creates the substrate for AF development 1, 2
- AF worsens SSS: Patients with frequent, repetitive, long-lasting episodes of AF may further remodel their atrial myocardium, including the sinoatrial region 1
- AF can unmask SSS: Some patients with sustained AF or flutter have underlying sinus node dysfunction that becomes apparent only after cardioversion of the atrial tachyarrhythmia 1
Recent research confirms this: SSS is associated with more than 10 times increased risk of developing AF 3, and conversely, incident AF increases the risk of SSS by 13.4-fold 3.
Clinical Recognition
When diagnosing SSS, clinicians must actively look for atrial tachyarrhythmias even if not initially recorded 1. The 2024 ESC AF Guidelines specifically recognize "sinus node disease/tachycardia-bradycardia syndrome" as a distinct clinical entity requiring consideration of AF catheter ablation 4.
Key clinical presentations include:
- Sudden oscillation between paroxysmal tachycardias and bradycardia upon termination 5
- Sinus pauses following AF termination (documented in 75% of SSS patients with paroxysmal AF) 6
- Symptoms at the termination of AF paroxysms that may require ambulatory monitoring for symptom-rhythm correlation 7
Treatment Implications
The presence of AF as part of SSS fundamentally alters management:
Anticoagulation consideration: When SSS is diagnosed, serious consideration should be given to oral anticoagulation therapy even if atrial tachyarrhythmias are not yet recorded, as they are likely to occur 1.
Pacing strategy: Physiological pacing (atrial or dual-chamber) definitively lowers the risk of developing AF compared to ventricular pacing alone 1, 8. The 2001 ESC Syncope Guidelines emphasize that VVI or VVIR pacing should be avoided in sick sinus syndrome specifically because it increases AF risk 8.
Catheter ablation option: The 2024 ESC Guidelines recommend that AF catheter ablation should be considered in patients with AF-related bradycardia or sinus pauses on AF termination to improve symptoms and potentially avoid pacemaker implantation 4. Research shows that 80.6% of SSS patients with paroxysmal AF remain free from arrhythmia recurrence after ablation, though 13.8% still require pacemaker implantation 6.
Common Pitfalls
Do not dismiss AF as a separate comorbidity in SSS patients—it is part of the disease spectrum and requires integrated management. The electrophysiological substrate is shared: age-related interstitial fibrosis affects both sinus node function and creates the atrial substrate for AF 9.
Do not assume pacing alone will prevent AF—while physiological pacing reduces AF risk compared to ventricular pacing, it does not eliminate it. Pacing primarily addresses the bradycardia component but does not fully correct the underlying atrial pathology 1.